{"entity":{"id":"robert-separovic","kind":"person","name":"Robert Šeparović","aka":[],"tldr":"Robert Šeparović represents University Hospital for Tumors, Sestre milosrdnice University Hospital Centre in the Organisation of European Cancer Institutes, which lists the centre among its members in Croatia.","summary":"Robert Šeparović is listed by the Organisation of European Cancer Institutes (OECI) as the representative of University Hospital for Tumors, Sestre milosrdnice University Hospital Centre, its full member in Croatia. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"University Hospital for Tumors, Sestre milosrdnice University Hospital Centre website","url":"http://www.kbcsm.hr/klinike/klinika-za-tumore"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sestre-milosrdnice-tumors"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of University Hospital for Tumors, Sestre milosrdnice University Hospital Centre to the Organisation of European Cancer Institutes","institutionId":"sestre-milosrdnice-tumors","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"University Hospital for Tumors, Sestre milosrdnice University Hospital Centre website","url":"http://www.kbcsm.hr/klinike/klinika-za-tumore"}],"papers":[{"title":"PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial","journal":"Breast Cancer Res","year":2019,"url":"https://doi.org/10.1186/s13058-019-1115-2","doi":"10.1186/s13058-019-1115-2","note":"Europe PMC author record matched by affiliation"},{"title":"CHARACTERISTICS AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A CROATIAN SINGLE INstitution RETROSPECTIVE COHORT STUDY","journal":"Acta Clin Croat","year":2020,"url":"https://doi.org/10.20471/acc.2020.59.01.12","doi":"10.20471/acc.2020.59.01.12","note":"Europe PMC author record matched by affiliation"},{"title":"THE ROLE OF SALIVARY AND SERUM CA125 AND ROUTINE BLOOD TESTS IN PATIENTS WITH OVARIAN MALIGNANCIES","journal":"Acta Clin Croat","year":2021,"url":"https://doi.org/10.20471/acc.2021.60.01.08","doi":"10.20471/acc.2021.60.01.08","note":"Europe PMC author record matched by affiliation"}]},"route":"/people/robert-separovic/","neighbours":{"institution":[{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"},{"id":"sestre-milosrdnice-tumors","kind":"institution","name":"University Hospital for Tumors, Sestre milosrdnice University Hospital Centre","route":"/institutions/sestre-milosrdnice-tumors/"}]}}